Literature DB >> 31289491

Caveolin-1 and dynamin-2 overexpression is associated with the progression of bladder cancer.

Sadaf Azad Raja1, Syed Tahir Abbas Shah1, Aamira Tariq1, Nazia Bibi1, Kalsoom Sughra2, Arzu Yousuf3, Athar Khawaja3, Muhammad Nawaz4, Arshad Mehmood4, Muhammad Jadoon Khan1, Alamdar Hussain1.   

Abstract

Caveolae-mediated endocytosis regulates cell adhesion and growth in an anchorage-dependent manner. Studies of the endocytic function of caveolae have suggested a wide-ranging list of cargoes, including a number of receptors and extracellular proteins, ligands and nutrients from the extracellular matrix. Disruption of the processes of caveolae-mediated endocytosis mediated by signaling proteins is critical to cellular integrity. Caveolin-1 and dynamin-2 are the 2 major proteins associated with endocytotic function. Mechanistically, dynamin-2 has a co-equal role with caveolin-1 in terms of caveolae-derived endosome formation. Recent studies have revealed the pathological outcomes associated with the dysregulation of caveolin-1 and dynamin-2 expression. Increased expression levels of the gene for caveolin, Cav-1, resulting in augmented cellular metastasis and invasion, have been demonstrated in various types of cancer, and overexpression of the gene for dynamin-2, DNM2, has been associated with tumorigenesis in cervical, pancreatic and lung cancer. An increased expression of Cav-1 and DNM2 is known to be associated with the invasive behavior of cancer cells, and with cancer progression. Furthermore, it has been previously demonstrated that, in caveolar assembly and caveolae mediated endocytosis, Cav-1 interacts directly with DNM2 during the processes. Altered expression of the 2 genes is critical for the normal function of the cell. The expression patterns of Cav-1 and DNM2 have been previously examined in bladder cancer cell lines, and were each demonstrated to be overexpressed. In the present study, the expression levels of these 2 genes in bladder cancer samples were quantified. The gene expression levels of Cav-1 and DNM2 were identified to be increased 8.88- and 8.62-fold, respectively, in tumors compared with the normal controls. Furthermore, high-grade tumors exhibited significantly increased expression levels of Cav-1 and DNM2 (both P<0.0001) compared with the low-grade tumors. In addition, compared with normal control samples, the expression of the 2 genes in tumor samples was observed to be highly significant (P<0.0001), with a marked positive correlation identified for the tumors (Pearson's correlation coefficient, r=0.80 for the tumor samples vs. r=0.32 in the normal control samples). Taken together, the results of the present study demonstrated that the overexpression of Cav-1 and DNM2 genes, and a determination of their correlation coefficients, may be a potential risk factor for bladder cancer, in addition to other clinical factors.

Entities:  

Keywords:  bladder cancer; caveolin-1; dynamin-2

Year:  2019        PMID: 31289491      PMCID: PMC6539888          DOI: 10.3892/ol.2019.10310

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  12 in total

1.  The role of caveolin-1 and endothelial nitric oxide synthase polymorphisms in susceptibility to prostate cancer.

Authors:  Mahdieh Aliyari; Daniel Elieh Ali Komi; Amir Kiani; Mahmoudreza Moradi; Maryam Tanhapour; Zohreh Rahimi; Hadi Mozafari; Ehsan Mohammadi-Noori; Tayebeh Pourmotabbed; Asad Vaisi-Raygani; Fariborz Bahrehmand
Journal:  Int J Exp Pathol       Date:  2021-05-08       Impact factor: 1.925

2.  Caveolin-1 regulates the expression of miR-183 and inhibits the invasion and migration of invasive pituitary adenomas by affecting early growth response 1 (EGR1)/Krueppel-like factor 5 (KLF5) interaction.

Authors:  Huan Ma; Zheying Zhang; Yang Wang; Fei Shang; Baoshun Du; Yungang Wang; Zhenguo Cheng
Journal:  Gland Surg       Date:  2020-12

3.  The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis.

Authors:  Mei Tian; Xiuchun Yang; Yanfang Li; Sen Guo
Journal:  Med Sci Monit       Date:  2020-06-23

Review 4.  Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer.

Authors:  L Simón; A Campos; L Leyton; A F G Quest
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

5.  Association of Caveolin-1 Expression With Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Pei Chen; Yu-Ling Zhang; Bai Xue; Guo-Ying Xu
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

6.  EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis.

Authors:  Chenying Fu; Qing Zhang; Ani Wang; Songpeng Yang; Yangfu Jiang; Lin Bai; Quan Wei
Journal:  Mol Oncol       Date:  2021-03-27       Impact factor: 6.603

7.  DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.

Authors:  Mingchao Hu; Jianchun Gu; Wenzhao Su; Zhenjie Zhang; Baosong Zhu; Qiang Wang; Chungen Xing
Journal:  Biomed Res Int       Date:  2021-11-30       Impact factor: 3.411

8.  CAV1 rs7804372 (T29107A) polymorphism might be a potential risk for digestive cancers: A protocol for systematic review and meta analysis.

Authors:  Pei Chen; Yu-Ling Zhang; Bai Xue; Ji-Ru Wang
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

Review 9.  Rafting Down the Metastatic Cascade: The Role of Lipid Rafts in Cancer Metastasis, Cell Death, and Clinical Outcomes.

Authors:  Joshua D Greenlee; Tejas Subramanian; Kevin Liu; Michael R King
Journal:  Cancer Res       Date:  2020-09-30       Impact factor: 13.312

Review 10.  A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target.

Authors:  Delphine Trochet; Marc Bitoun
Journal:  J Exp Clin Cancer Res       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.